Prevention and Prophylaxis of Cancer Associated Thrombosis in High Risk Oncology Patients (NCT03909399) | Clinical Trial Compass
UnknownNot Applicable
Prevention and Prophylaxis of Cancer Associated Thrombosis in High Risk Oncology Patients
Greece500 participantsStarted 2019-01-25
Plain-language summary
Prevention and Prophylaxis (Thromboprophylaxis - ACT) of Cancer Associated Thrombosis (CAT) in High Risk Oncology Patients: ACT4CAT.
Who can participate
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
* Patients who were diagnosed with histological confirmed high thrombotic risk cancers (GI, thoracic, gynecologic, genitourinary or CNS).
* Patients who have already started on thromboprophylaxis treatment according to the current clinical practice guidelines and the clinical judgment of treating physician after discussion with patient, within three months before the study enrollment.
* Age ≥ 18 years
* ECOG 0-2
* Life expectancy \>6 months
* Signed informed consent
Exclusion criteria
* Patients who were not diagnosed with histological confirmed high thrombotic risk cancers (GI, thoracic, gynecologic, genitourinary or CNS).
* Patients who have not already started on thromboprophylaxis treatment according to the current clinical practice guidelines or who have already started on thromboprophylaxis but more than three months before the study enrollment.
* Age \< 18 years
* ECOG \>2
* Life expectancy \<6 months
* Not signed informed consent
What they're measuring
1
Recording all objectively confirmed VTE events for 500 patients during the treatment period